Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Eveline M Delemarre"'
Autor:
Paula Niewold, Douwe J. Dijkstra, Yi Cai, Delia Goletti, Fabrizio Palmieri, Krista E. van Meijgaarden, Frank A. W. Verreck, Onno W. Akkerman, Regina W. Hofland, Eveline M. Delemarre, Stefan Nierkens, Marije K. Verheul, Andrew J. Pollard, Jaap T. van Dissel, Tom H. M. Ottenhoff, Leendert A. Trouw, Simone A. Joosten
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6 million new cases annually. Discriminating TB disease from differential diagnoses can be complex, particularly in the field. Increased levels of comple
Externí odkaz:
https://doaj.org/article/571b4883ecfe424fa808ac326e39113b
Autor:
Mick J.M. van Eijs, José J.M. ter Linde, Matthijs J.D. Baars, Mojtaba Amini, Miangela M. Laclé, Eelco C. Brand, Eveline M. Delemarre, Julia Drylewicz, Stefan Nierkens, Rik J. Verheijden, Bas Oldenburg, Yvonne Vercoulen, Karijn P.M. Suijkerbuijk, Femke van Wijk
Publikováno v:
iScience, Vol 26, Iss 10, Pp 107891- (2023)
Summary: Colitis is a prevalent adverse event associated with immune checkpoint inhibitor (ICI) therapy with similarities to inflammatory bowel disease. Incomplete mechanistic understanding of ICI colitis curtails evidence-based treatment. Given the
Externí odkaz:
https://doaj.org/article/275e4beac3b94af3a05ead771f3af228
Autor:
Eveline M. Delemarre, Laura van Hoorn, Aik W. J. Bossink, Julia Drylewicz, Simone A. Joosten, Tom H. M. Ottenhoff, Onno W. Akkerman, Delia Goletti, Elisa Petruccioli, Assunta Navarra, Brigitte T. A. van den Broek, Sanne P. A. Paardekooper, Ineke van Haeften, Leo Koenderman, Jan-Willem J. Lammers, Steven F. T. Thijsen, Regina W. Hofland, Stefan Nierkens
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionThere is an urgent medical need to differentiate active tuberculosis (ATB) from latent tuberculosis infection (LTBI) and prevent undertreatment and overtreatment. The aim of this study was to identify biomarker profiles that may support t
Externí odkaz:
https://doaj.org/article/32e9ffc238fc4966a4cd5c1d10890db9
Autor:
Alinda G. Vos, Caitlin N. Dodd, Eveline M. Delemarre, Stefan Nierkens, Celicia Serenata, Diederick E. Grobbee, Kerstin Klipstein-Grobusch, W. D. Francois Venter
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionInsight into inflammation patterns is needed to understand the pathophysiology of HIV and related cardiovascular disease (CVD). We assessed patterns of inflammation related to HIV infection and CVD risk assessed with carotid intima media
Externí odkaz:
https://doaj.org/article/f795f2a477e44da6924b95009a898047
Autor:
Helen J. von Richthofen, Geertje H.A. Westerlaken, Doron Gollnast, Sjanna Besteman, Eveline M. Delemarre, Karlijn Rodenburg, Petra Moerer, Daphne A.C. Stapels, Anand K. Andiappan, Olaf Rötzschke, Stefan Nierkens, Helen L. Leavis, Louis J. Bont, Suzan H.M. Rooijakkers, Linde Meyaard
Publikováno v:
J Immunol
Signal inhibitory receptor on leukocytes-1 (SIRL-1) is an immune inhibitory receptor expressed on human granulocytes and monocytes which dampens antimicrobial functions. We previously showed that sputum neutrophils from infants with severe respirator
Autor:
Marjolein P M Hensgens, Eveline M Delemarre, Julia Drylewicz, Mareye Voortman, Roline M Krol, Virgil A S H Dalm, Jelle R Miedema, Ivo Wiertz, Jan Grutters, Maarten Limper, Stefan Nierkens, Helen L Leavis
Publikováno v:
Rheumatology (Oxford, England), 61(10), 4087-4096. Oxford University Press
Objectives The presence of melanoma differentiation-associated protein 5 (MDA5) antibodies in patients with DM is associated with the development of a rapidly progressive interstitial lung disease (RPILD), unresponsive to conventional treatment. We c
Autor:
Mick J.M. van Eijs, José J.M. ter Linde, Matthijs J.D. Baars, Mojtaba Amini, Miangela M. Laclé, Eelco C. Brand, Eveline M. Delemarre, Julia Drylewicz, Stefan Nierkens, Rik J. Verheijden, Bas Oldenburg, Yvonne Vercoulen, Karijn P.M. Suijkerbuijk, Femke van Wijk
SummaryColitis is a prevalent adverse event associated with immune checkpoint inhibitor (ICI) therapy with similarities to inflammatory bowel disease. Incomplete mechanistic understanding of ICI-colitis curtails evidence-based treatment. Given the of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5997e56a68279f536b5b24ab95ddd64
https://doi.org/10.1101/2023.04.25.23289056
https://doi.org/10.1101/2023.04.25.23289056
Autor:
Daphne S. Bakker, Marjolein S. de Bruin-Weller, Judith L. Thijs, Marlies de Graaf, Stefan Nierkens, Edward F. Knol, Eveline M. Delemarre, Julia Drylewicz, Femke van Wijk
Publikováno v:
Journal of Allergy and Clinical Immunology. 149:125-134
Background Increasing evidence shows that pediatric atopic dermatitis (AD) differs from adult AD on a biologic level. Broad biomarker profiling across a wide range of ages of pediatric patients with AD is lacking. Objective Our aim was to identify se
Autor:
Nanda M. Verhoeven-Duif, Brigitte T.A. van den Broek, Jaap Jan Boelens, Peter M. van Hasselt, Stefan Nierkens, Caroline A. Lindemans, Julia Drylewicz, Eveline M. Delemarre
Publikováno v:
Blood Adv
Mucopolysaccharidoses (MPS) are devastating inherited diseases treated with hematopoietic cell transplantation (HCT). However, disease progression, especially skeletal, still occurs in all patients. Secondary inflammation has been hypothesized to be
Autor:
Judith L. Thijs, Eveline M. Delemarre, Jorien van der Schaft, Marjolein S. de Bruin-Weller, Edward F. Knol, Stefan Nierkens, Julia Drylewicz, Femke van Wijk, Barbara Giovannone, Daphne S. Bakker
Publikováno v:
Journal of Allergy and Clinical Immunology. 147:189-198
Background Atopic dermatitis (AD) is a highly heterogeneous disease, both clinically and biologically, whereas patients are still being treated according to a “one-size-fits-all” approach. Stratification of patients into biomarker-based endotypes